| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.014 | 0.8 |